NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-DA-22-029 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research project applications that are developmental and exploratory in nature to expand our knowledge on the basic neurobiology of the interrelationship between sleep and substance use disorders (SUDs). These mechanistic studies will not only offer an insight into the fundamental processes that link substance use disorders to disorders of sleep regulation and vice-versa but may also have implications for managing risk for the development of SUDs and identifying new targets for prevention and therapeutics.
Funding Opportunity RFA-DE-22-004 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to solicit research to better understand the epidemiology and biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV.
Notice NOT-OD-21-137 from the NIH Guide for Grants and Contracts
Notice NOT-RM-21-030 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-127 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-204 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.
Funding Opportunity RFA-MH-21-241 from the NIH Guide for Grants and Contracts. Companion of RFA-MH-21-240 This Funding Opportunity Announcement (FOA) encourages research that addresses major research gaps identified by the United States Preventive Services Task Force (USPSTF): 1) Identify who is at increased risk for perinatal depression and would benefit the most from preventive interventions; and 2) Determine ways to improve the delivery of interventions to prevent perinatal depression. This FOA emphasizes underserved populations.
Funding Opportunity RFA-MH-21-240 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research that addresses major research gaps identified by the United States Preventive Services Task Force (USPSTF): 1) Identify who is at increased risk for perinatal depression and would benefit the most from preventive interventions; and 2) Determine ways to improve the delivery of interventions to prevent perinatal depression. This FOA emphasizes underserved populations.
Funding Opportunity RFA-ES-21-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research seeking to understand mechanisms of chemical toxicity and to identify potential molecular/genetic targets that reduce acute effects of chemical threat agents that affect the eyes and lungs. These discoveries can lead to exploration of therapeutic countermeasures through early stage development efforts supported by the Countermeasures Against Chemical Threats (CounterACT) NIH-wide program, a component within the Chemical Countermeasures Research Program (CCRP).
Notice NOT-AI-21-062 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-249 from the NIH Guide for Grants and Contracts. This funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications. Areas of Research Collaboration: Applications are encouraged from organization/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collaborations with Indian investigators on the following: diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, including rare and genetic diseases such as congenital cataracts, as well as other eye conditions such as ocular inflammation/uveitis, refractive error, low vision, and corneal injury. Basic, translational, or epidemiological research maybe proposed. Clinical trials will not be supported under this FOA.
Funding Opportunity RFA-DC-22-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact.
Funding Opportunity RFA-DK-21-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D) to avoid acute complications at diagnosis and to allow earlier interventions to prevent and/or delay clinical manifestations and long term complications of the disease.
Notice NOT-AI-21-057 from the NIH Guide for Grants and Contracts
Notice NOT-AG-21-018 from the NIH Guide for Grants and Contracts
Notice NOT-AA-21-029 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-21-275 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support innovative population-based research that can contribute to identifying and characterizing pathways and mechanisms through which work or occupation influences health outcomes and health status among populations with health and/or health care disparities, and how work functions as a social determinant of health.
Funding Opportunity RFA-CA-21-026 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is publishing this Funding Opportunity Announcement (FOA) to request applications for the Program on the Origins of Gastroesophageal Cancers (R01). This new program will build on recent molecular classifications of gastroesophageal cancers, significant understanding of their cancer genomics, and advances in stem cell research to examine and define how these related cancers initially evolve at the cellular level. The program will address the complex mechanisms and effectors that direct the proliferation and expansion of tumor-initiating cells and their progeny to initiate these cancers. The focus of the FOA is on gastric and gastroesophageal junction adenocarcinomas. The program is envisioned to provide unprecedented opportunities to outline the earliest cellular changes in transformation that precede any histological manifestations or neoplasia. This new program will be composed of up to six large R01 research grants (to be supported by this FOA) and one Coordinating Center grant (to be supported by the companion FOA, RFA-CA-21-027).
Funding Opportunity RFA-CA-21-027 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is publishing this Funding Opportunity Announcement (FOA) to request applications for the Coordinating Center, Program on the Origins of Gastroesophageal Cancers (U24). This new program will build on recent molecular classifications of gastroesophageal cancers, significant understanding of their cancer genomics, and advances in stem cell research to examine and define how these related cancers initially evolve at the cellular level. The program will address the complex mechanisms and effectors that direct the proliferation and expansion of tumor-initiating cells and their progeny to initiate these cancers. The focus of the FOA is on gastric and gastroesophageal junction adenocarcinomas. The program is envisioned to provide unprecedented opportunities to outline the earliest cellular changes in transformation that precede any histological manifestations or neoplasia. This new program will be composed of up to six large R01 research grants (to be supported by RFA-CA-21-026) and one Coordinating Center grant (to be supported by this FOA).
Notice NOT-CA-21-091 from the NIH Guide for Grants and Contracts